Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance

類似資料

• Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors
  著者:: Shinohara, Mitsuru, 等
  出版事項: (2014)
• Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes
  著者:: Takeda, Shuko, 等
  出版事項: (2010)
• A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke
  著者:: Kurinami, Hitomi, 等
  出版事項: (2016)
• The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease
  著者:: Sato, Naoyuki, 等
  出版事項: (2015)
• Therapeutic vaccine for chronic diseases after the COVID-19 Era
  著者:: Nakagami, Hironori, 等
  出版事項: (2021)